Insider Transactions in Q1 2025 at Verisign Inc (VRSN)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 24
2025
|
John Calys SVP, Cont., Chief Acct Officer |
SELL
Open market or private sale
|
Direct |
447
-1.85%
|
$103,257
$231.75 P/Share
|
Feb 18
2025
|
Kathleen A Cote Director |
SELL
Open market or private sale
|
Direct |
3,000
-9.89%
|
$690,000
$230.0 P/Share
|
Feb 18
2025
|
Danny R Mc Pherson EVP - Technology & CSO |
SELL
Open market or private sale
|
Direct |
5,500
-14.88%
|
$1,265,000
$230.73 P/Share
|
Feb 15
2025
|
John Calys SVP, Cont., Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
295
-0.3%
|
$67,555
$229.24 P/Share
|
Feb 15
2025
|
Danny R Mc Pherson EVP - Technology & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,496
-0.98%
|
$342,584
$229.24 P/Share
|
Feb 15
2025
|
D James Bidzos Exec. Chairman, Pres, & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,617
-0.16%
|
$828,293
$229.24 P/Share
|
Feb 15
2025
|
George E Kilguss Iii EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,573
-0.31%
|
$360,217
$229.24 P/Share
|
Feb 15
2025
|
Thomas C Indelicarto EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,474
-0.84%
|
$337,546
$229.24 P/Share
|
Feb 14
2025
|
Danny R Mc Pherson EVP - Technology & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
293
-0.76%
|
$67,097
$229.24 P/Share
|
Feb 14
2025
|
Danny R Mc Pherson EVP - Technology & CSO |
BUY
Grant, award, or other acquisition
|
Direct |
700
+1.77%
|
-
|
Feb 13
2025
|
Thomas C Indelicarto EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,276
-2.8%
|
$292,204
$229.34 P/Share
|
Feb 13
2025
|
Thomas C Indelicarto EVP, Gen Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
4,158
+8.36%
|
-
|
Feb 13
2025
|
John Calys SVP, Cont., Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
446
-1.79%
|
$102,134
$229.34 P/Share
|
Feb 13
2025
|
John Calys SVP, Cont., Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,386
+5.27%
|
-
|
Feb 13
2025
|
Danny R Mc Pherson EVP - Technology & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,274
-3.24%
|
$291,746
$229.34 P/Share
|
Feb 13
2025
|
Danny R Mc Pherson EVP - Technology & CSO |
BUY
Grant, award, or other acquisition
|
Direct |
4,158
+9.56%
|
-
|
Feb 13
2025
|
D James Bidzos Exec. Chairman, Pres, & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,723
-1.18%
|
$1,539,567
$229.34 P/Share
|
Feb 13
2025
|
D James Bidzos Exec. Chairman, Pres, & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,710
+3.18%
|
-
|
Feb 13
2025
|
George E Kilguss Iii EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,558
-1.23%
|
$356,782
$229.34 P/Share
|
Feb 13
2025
|
George E Kilguss Iii EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,850
+3.68%
|
-
|
Feb 10
2025
|
Thomas C Indelicarto EVP, Gen Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
8,324
+16.73%
|
-
|
Feb 10
2025
|
Danny R Mc Pherson EVP - Technology & CSO |
BUY
Grant, award, or other acquisition
|
Direct |
8,999
+20.37%
|
-
|
Feb 10
2025
|
John Calys SVP, Cont., Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,474
+9.51%
|
-
|
Feb 10
2025
|
D James Bidzos Exec. Chairman, Pres, & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
23,398
+4.07%
|
-
|
Feb 10
2025
|
George E Kilguss Iii EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,878
+6.06%
|
-
|
Jan 15
2025
|
Danny R Mc Pherson EVP - Technology & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
20
-0.08%
|
$4,200
$210.1 P/Share
|
Jan 03
2025
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect |
12,544
+0.05%
|
$2,558,976
$204.78 P/Share
|
Jan 02
2025
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect |
5,879
+0.04%
|
$1,199,316
$204.84 P/Share
|